Methylxanthines for the prevention or treatment of intermittent hypoxemia or respiratory insufficiency in late preterm infants
{{output}}
Rationale: Late preterm infants (34 0/7 to 36 6/7 weeks' gestation, i.e. 34 weeks and 0 days to 36 weeks and 6 days) are at increased risk of intermittent hypoxemia and respiratory insufficiency due to physiological immaturity, ... ...
